• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    7.26 Down 0.12(1.63%) Feb 5, 4:00PM EST
    |After Hours : 7.24 Down 0.02 (0.28%) Feb 5, 7:53PM EST
    Prev Close:7.38
    Open:7.35
    Bid:7.24 x 500
    Ask:N/A
    1y Target Est:34.00
    Beta:3.52636
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:6.70 - 7.54
    52wk Range:6.70 - 32.82
    Volume:7,445,726
    Avg Vol (3m):2,437,500
    Market Cap:716.17M
    P/E (ttm):N/A
    EPS (ttm):-1.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CLDXDown 1.63%716.17M
    LLYUp 0.05%78.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):140.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.32
    Quarterly EPS Est (Dec-15) :-0.35
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback